<?xml version="1.0" encoding="UTF-8"?>
<results title="sars_covid_2">
 <result pre="10.1080/22221751.2020.1713705 : Article Polymorphisms in dipeptidyl peptidase 4 reduce host" exact="cell entry" post="of Middle East respiratory syndrome coronavirus Emerging Microbes &amp;amp;"/>
 <result pre="Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus Emerging Microbes &amp;amp; Infections H. Kleine-weber et al."/>
 <result pre="provided the original work is properly cited. TEMI_9_1713705.pdf Abstract ABSTRACT" exact="Middle East respiratory syndrome" post="(MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in"/>
 <result pre="coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The" exact="MERS-CoV" post="spike (S) glycoprotein mediates viral entry into target cells."/>
 <result pre="(S) glycoprotein mediates viral entry into target cells. For this," exact="MERS-CoV" post="S engages the host cell protein dipeptidyl peptidase 4"/>
 <result pre="protein dipeptidyl peptidase 4 (DPP4, CD26) and the interface between" exact="MERS-CoV" post="S and DPP4 has been resolved on the atomic"/>
 <result pre="polymorphisms in DPP4, that alter amino acid residues required for" exact="MERS-CoV" post="S binding, influence cellular entry of MERS-CoV. By screening"/>
 <result pre="polymorphisms (K267E, K267N, A291P and Δ346-348) strongly reduced binding of" exact="MERS-CoV" post="S to DPP4 and S protein-driven host cell entry,"/>
 <result pre="binding of MERS-CoV S to DPP4 and S protein-driven host" exact="cell entry," post="as determined using soluble S protein and S protein"/>
 <result pre="(K267E and A291P) were analyzed in the context of authentic" exact="MERS-CoV" post="and were found to attenuate viral replication. Collectively, we"/>
 <result pre="naturally-occurring polymorphisms in DPP4 that negatively impact cellular entry of" exact="MERS-CoV" post="and might thus modulate MERS development in infected patients."/>
 <result pre="and might thus modulate MERS development in infected patients. KEYWORDS" exact="Middle East respiratory syndrome" post="coronavirus spike glycoprotein dipeptidyl peptidase 4 polymorphisms receptor binding"/>
 <result pre="the work for publication. fig-count: table-count: equation-count: ref-count: page-count: Introduction" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) is an enveloped virus with a single-stranded"/>
 <result pre="single-stranded RNA genome of positive polarity. It belongs to the" exact="Coronaviridae" post="family (genus Betacoronavirus), which is part of the order"/>
 <result pre="family (genus Betacoronavirus), which is part of the order Nidovirales." exact="MERS-CoV" post="was isolated in 2012 from the sputum of a"/>
 <result pre="renal failure in Saudi Arabia [ 1]. Since its discovery," exact="MERS-CoV" post="has caused 2,442 human infections of which 842 (34.5%)"/>
 <result pre="May, 2019) [ 2]. Dromedary camels are reservoir hosts of" exact="MERS-CoV" post="and display only common cold-like symptoms upon infection but"/>
 <result pre="DPP4, were recently suggested to account for the differences in" exact="MERS-CoV" post="transmission and disease induction in camels and humans, respectively"/>
 <result pre="were recently suggested to account for the differences in MERS-CoV" exact="transmission" post="and disease induction in camels and humans, respectively ["/>
 <result pre="14]. In order to infect a host (cell) and replicate," exact="MERS-CoV" post="has to deliver its genome into the cellular cytoplasm"/>
 <result pre="spike (S) glycoprotein, a type-I transmembrane protein embedded in the" exact="viral envelope." post="For host cell entry, the surface unit, S1, of"/>
 <result pre="type-I transmembrane protein embedded in the viral envelope. For host" exact="cell entry," post="the surface unit, S1, of MERS-CoV S binds to"/>
 <result pre="envelope. For host cell entry, the surface unit, S1, of" exact="MERS-CoV" post="S binds to the cellular type-II transmembrane protein dipeptidyl"/>
 <result pre="in the viral S protein [ 16]. Upon DPP4 engagement," exact="MERS-CoV" post="S undergoes proteolytic activation through the cellular serine protease"/>
 <result pre="MERS-CoV S undergoes proteolytic activation through the cellular serine protease" exact="TMPRSS2" post="or the endosomal cysteine protease cathepsin L [ 17–19],"/>
 <result pre="L [ 17–19], which allows the transmembrane unit, S2, of" exact="MERS-CoV" post="S to fuse the viral membrane with cellular membranes."/>
 <result pre="transmembrane unit, S2, of MERS-CoV S to fuse the viral" exact="membrane" post="with cellular membranes. DPP4 is a prolyl oligopeptidase that"/>
 <result pre="metabolism [ 25]. Mature DPP4 is embedded in the plasma" exact="membrane" post="as a homodimer and each monomer consists of an"/>
 <result pre="and myocardial infarction [ 29] but their potential impact on" exact="MERS-CoV" post="infection has not been analyzed. We asked whether naturally-occurring"/>
 <result pre="naturally-occurring amino acid polymorphisms in DPP4 residues making contact with" exact="MERS-CoV" post="S have an impact on MERS-CoV entry. We identified"/>
 <result pre="residues making contact with MERS-CoV S have an impact on" exact="MERS-CoV" post="entry. We identified fourteen polymorphisms by screening public databases"/>
 <result pre="a DPP4 expression plasmid. We identified four mutations that reduced" exact="MERS-CoV" post="S binding to DPP4 and MERS-CoV S-driven host cell"/>
 <result pre="four mutations that reduced MERS-CoV S binding to DPP4 and" exact="MERS-CoV" post="S-driven host cell entry without affecting DPP4 expression at"/>
 <result pre="reduced MERS-CoV S binding to DPP4 and MERS-CoV S-driven host" exact="cell entry" post="without affecting DPP4 expression at the cell surface. Materials"/>
 <result pre="pCAGGS-based expression vectors for vesicular stomatitis virus (VSV) glycoprotein (G)," exact="MERS-CoV" post="S wildtype (WT) and MERS-CoV S (D510G) (the latter"/>
 <result pre="stomatitis virus (VSV) glycoprotein (G), MERS-CoV S wildtype (WT) and" exact="MERS-CoV" post="S (D510G) (the latter two either untagged or equipped"/>
 <result pre="[ 35–37]. In addition, a previously described expression vector for" exact="angiotensin converting enzyme 2" post="was employed [ 38]. Similar to the strategy used"/>
 <result pre="overlap-extension PCR technique to introduce a single mutation into the" exact="MERS-CoV" post="S open reading frame, thus generating untagged and V5-tagged"/>
 <result pre="MERS-CoV S open reading frame, thus generating untagged and V5-tagged" exact="MERS-CoV" post="S (D539N). Soluble S comprising the S1 subdomain of"/>
 <result pre="MERS-CoV S (D539N). Soluble S comprising the S1 subdomain of" exact="MERS-CoV" post="S (aa residues: 1–747) fused to a human IgG"/>
 <result pre="the respective DPP4 mutants was calculated accordingly. Production of soluble" exact="MERS-CoV" post="S and binding studies In order to generate soluble"/>
 <result pre="MERS-CoV S and binding studies In order to generate soluble" exact="MERS-CoV" post="S for binding studies, 293T cells were transfected with"/>
 <result pre="transfected with an expression vector for the S1 subunit of" exact="MERS-CoV" post="S fused to the Fc fragment of human immunoglobulin"/>
 <result pre="4 °C until the sample was 10-fold concentrated. Analysis of" exact="MERS-CoV" post="S / DPP4 interaction with soluble MERS-CoV s1 by"/>
 <result pre="concentrated. Analysis of MERS-CoV S / DPP4 interaction with soluble" exact="MERS-CoV" post="s1 by flow cytometry For the binding studies with"/>
 <result pre="respective DPP4 mutants or ACE2 were calculated accordingly. Analysis of" exact="MERS-CoV" post="S / DPP4 interaction by co-immunoprecipitation 293T cells (grown"/>
 <result pre="for variations in transfection efficiency and sample processing. Analysis of" exact="MERS-CoV" post="S / DPP4 interaction using soluble DPP4 Ligand For"/>
 <result pre="with expression vectors for WT or mutant (D510G and D539N)" exact="MERS-CoV" post="S, or empty expression vector (negative control) were analyzed"/>
 <result pre="from all samples. Further, binding of solDPP4-Fc to cells expressing" exact="MERS-CoV" post="S WT was set as 100% and the relative"/>
 <result pre="and the relative binding efficiencies to cells expressing the respective" exact="MERS-CoV" post="S mutants were calculated accordingly. Generation of rhabdoviral pseudotypes"/>
 <result pre="40]. In brief, 293T cells transfected with expression vectors for" exact="MERS-CoV" post="S, VSV-G (positive control) or empty expression vector (negative"/>
 <result pre="Beetle-Juice kit (PJK) and a plate luminometer (Hidex) [ 41]." exact="MERS-CoV" post="infection and quantification of viral titers BHK-21 cells were"/>
 <result pre="manufacturer’s instructions. At 24 h posttransfection, the cells were infected with" exact="MERS-CoV" post="(Human betacoronavirus 2c EMC/2012, MERS-CoV EMC-2012, GenBank accession number:"/>
 <result pre="the cells were infected with MERS-CoV (Human betacoronavirus 2c EMC/2012," exact="MERS-CoV" post="EMC-2012, GenBank accession number: JX869059) at a multiplicity of"/>
 <result pre="[ 42]. In vitro-transcribed standard samples containing defined amounts of" exact="MERS-CoV" post="fragments (10, 100, 1,000 and 10,000 copies) were included"/>
 <result pre="43] and the structure of the complex formed by the" exact="MERS-CoV" post="S receptor binding domain bound to DPP4 (4L72) ["/>
 <result pre="DPP4 that alter amino acid residues which make contact with" exact="MERS-CoV" post="S The binding interface between MERS-CoV S and the"/>
 <result pre="which make contact with MERS-CoV S The binding interface between" exact="MERS-CoV" post="S and the cellular receptor DPP4 was resolved by"/>
 <result pre="residues for each binding partner [ 16]: Fourteen residues of" exact="MERS-CoV" post="S (Y499, N501, K502, L506, D510, R511, E513, D537"/>
 <result pre="amino acid residues in DPP4 at the binding interface with" exact="MERS-CoV" post="S. (A) Schematic representation of DPP4 (CD26). Highlighted are"/>
 <result pre="the positions of amino acid residues that directly interact with" exact="MERS-CoV" post="S (grey triangles mark residues for which no polymorphism"/>
 <result pre="the border between the two monomers and the cellular plasma" exact="membrane" post="is schematically depicted below the side view model of"/>
 <result pre="(4PV7) deposited in RSCB PDB and the binding interface with" exact="MERS-CoV" post="S has been highlighted (green). (C) Close-up on the"/>
 <result pre="(C) Close-up on the DPP4 residues that directly interact with" exact="MERS-CoV" post="S and for which no polymorphic (yellow) or polymorphic"/>
 <result pre="residues (letters in brackets), and the corresponding interacting residues in" exact="MERS-CoV" post="S (italicized letters and numbers) are indicated. (D) Frequency"/>
 <result pre="In order to identify polymorphic residues in DPP4 that contact" exact="MERS-CoV" post="S, we screened public databases that provide information on"/>
 <result pre="that nine out of the fifteen DPP4 residues interacting with" exact="MERS-CoV" post="S are polymorphic (K267, Q286, T288, A289, A291, R317,"/>
 <result pre="2A-B). As DPP4 needs to be transported to the plasma" exact="membrane" post="to be engaged by MERS-CoV S for host cell"/>
 <result pre="be transported to the plasma membrane to be engaged by" exact="MERS-CoV" post="S for host cell entry, we next investigated whether"/>
 <result pre="plasma membrane to be engaged by MERS-CoV S for host" exact="cell entry," post="we next investigated whether the presence of the polymorphic"/>
 <result pre="harboring polymorphic amino acid residues at the binding interface with" exact="MERS-CoV" post="S are robustly expressed. (A) Wildtype (WT) and mutant"/>
 <result pre="harboring polymorphic amino acid residues at the binding interface with" exact="MERS-CoV" post="S are efficiently transported to the cell surface. (A)"/>
 <result pre="positions 267 and 291 in DPP4 reduce S protein-driven host" exact="cell entry" post="and replication of authentic MERS-CoV We next investigated whether"/>
 <result pre="reduce S protein-driven host cell entry and replication of authentic" exact="MERS-CoV" post="We next investigated whether polymorphic DPP4 residues impact MERS-CoV"/>
 <result pre="authentic MERS-CoV We next investigated whether polymorphic DPP4 residues impact" exact="MERS-CoV" post="host cell entry. For this, we made use of"/>
 <result pre="We next investigated whether polymorphic DPP4 residues impact MERS-CoV host" exact="cell entry." post="For this, we made use of vesicular stomatitis virus"/>
 <result pre="made use of vesicular stomatitis virus (VSV) pseudotypes (VSVpp) bearing" exact="MERS-CoV" post="S or VSV G, which does not bind to"/>
 <result pre="DPP4 expression. In contrast, transduction of BHK-21 cells mediated by" exact="MERS-CoV" post="S critically depended on ectopic expression of human DPP4,"/>
 <result pre="polymorphisms - K267E, K267N, A291P and Δ346–348 - severely reduced" exact="MERS-CoV" post="S-driven transduction compared to DPP4 WT ( Figure 4)."/>
 <result pre="Figure 4). In order to analyze whether the reduction in" exact="MERS-CoV" post="S-driven host cell entry would translate into attenuated MERS-CoV"/>
 <result pre="order to analyze whether the reduction in MERS-CoV S-driven host" exact="cell entry" post="would translate into attenuated MERS-CoV replication, we next investigated"/>
 <result pre="in MERS-CoV S-driven host cell entry would translate into attenuated" exact="MERS-CoV" post="replication, we next investigated two DPP4 polymorphisms (K267E and"/>
 <result pre="period of two days post infection it was observed that" exact="MERS-CoV" post="replication in BHK-21 cells expressing human DPP4 was significantly"/>
 <result pre="amino acid residues in DPP4 that do not support efficient" exact="MERS-CoV" post="S-driven host cell entry. (A) To investigate whether mutant"/>
 <result pre="in DPP4 that do not support efficient MERS-CoV S-driven host" exact="cell entry." post="(A) To investigate whether mutant DPP4 support host cell"/>
 <result pre="cell entry. (A) To investigate whether mutant DPP4 support host" exact="cell entry" post="driven by MERS-CoV S, we produced vesicular stomatitis virus"/>
 <result pre="investigate whether mutant DPP4 support host cell entry driven by" exact="MERS-CoV" post="S, we produced vesicular stomatitis virus pseudotype particles (VSVpp)"/>
 <result pre="S, we produced vesicular stomatitis virus pseudotype particles (VSVpp) harboring" exact="MERS-CoV" post="S (left) or VSV G (control, right). VSVpp were"/>
 <result pre="harboring polymorphic amino acid residues at the binding interface with" exact="MERS-CoV" post="S poorly support replication of live MERS-CoV. Two DPP4"/>
 <result pre="live MERS-CoV. Two DPP4 mutants that showed reduced compatibility for" exact="MERS-CoV" post="S-driven host cell entry (K267E and A291P) were analyzed"/>
 <result pre="DPP4 mutants that showed reduced compatibility for MERS-CoV S-driven host" exact="cell entry" post="(K267E and A291P) were analyzed in the context of"/>
 <result pre="before they received fresh culture medium and were further incubated." exact="MERS-CoV" post="replication was analyzed at 0, 24 and 48 h postinfection"/>
 <result pre="was analyzed at 0, 24 and 48 h postinfection by determining" exact="MERS-CoV" post="genome equivalents (GE) in the culture supernatant (given as"/>
 <result pre="Error bars indicate the SEM. Statistical significance of differences in" exact="MERS-CoV" post="replication in cells expressing WT or mutant DPP4 was"/>
 <result pre="ns; p ≤ 0.05, *). DPP4 polymorphisms K267E, K267N and A291P reduce" exact="MERS-CoV" post="S binding efficiency to DPP4 After the identification of"/>
 <result pre="reduce S-driven cellular entry of rhabdoviral vectors as well as" exact="MERS-CoV" post="replication, we next sought to investigate whether the attenuating"/>
 <result pre="whether the attenuating phenotype was due to reduced binding of" exact="MERS-CoV" post="S to DPP4. For this, we used soluble MERS-CoV"/>
 <result pre="of MERS-CoV S to DPP4. For this, we used soluble" exact="MERS-CoV" post="S, produced by fusing the S1 subunit, which contains"/>
 <result pre="K267E, K267N or A291P, which were not compatible with efficient" exact="MERS-CoV" post="S-driven host cell entry, displayed significantly reduced ability to"/>
 <result pre="A291P, which were not compatible with efficient MERS-CoV S-driven host" exact="cell entry," post="displayed significantly reduced ability to interact with MERS-CoV S"/>
 <result pre="host cell entry, displayed significantly reduced ability to interact with" exact="MERS-CoV" post="S as indicated by weaker DPP4 signals upon protein"/>
 <result pre="by flow cytometry. It was revealed that polymorphisms that reduced" exact="MERS-CoV" post="S-driven host cell entry (K267E, K267N, A291P and Δ346–348)"/>
 <result pre="It was revealed that polymorphisms that reduced MERS-CoV S-driven host" exact="cell entry" post="(K267E, K267N, A291P and Δ346–348) and spread of authentic"/>
 <result pre="entry (K267E, K267N, A291P and Δ346–348) and spread of authentic" exact="MERS-CoV" post="(K267E and A291P) also reduced MERS-CoV S binding to"/>
 <result pre="and spread of authentic MERS-CoV (K267E and A291P) also reduced" exact="MERS-CoV" post="S binding to cells expressing DPP4 on the cell"/>
 <result pre="surface ( Figure 6C). In addition, polymorphism A289V, which decreased" exact="MERS-CoV" post="S-driven transduction to a lesser extent than the aforementioned"/>
 <result pre="extent than the aforementioned polymorphisms ( Figure 4), also reduced" exact="MERS-CoV" post="S binding to DPP4. Thus, DPP4 polymorphisms K267E, K267N"/>
 <result pre="to DPP4. Thus, DPP4 polymorphisms K267E, K267N and A291P reduce" exact="MERS-CoV" post="S-driven host cell entry and MERS-CoV infection by diminishing"/>
 <result pre="DPP4 polymorphisms K267E, K267N and A291P reduce MERS-CoV S-driven host" exact="cell entry" post="and MERS-CoV infection by diminishing MERS-CoV S binding to"/>
 <result pre="K267N and A291P reduce MERS-CoV S-driven host cell entry and" exact="MERS-CoV" post="infection by diminishing MERS-CoV S binding to DPP4. Figure"/>
 <result pre="MERS-CoV S-driven host cell entry and MERS-CoV infection by diminishing" exact="MERS-CoV" post="S binding to DPP4. Figure 6. Reduced MERS-CoV S-driven"/>
 <result pre="by diminishing MERS-CoV S binding to DPP4. Figure 6. Reduced" exact="MERS-CoV" post="S-driven host cell entry is caused by inefficient S"/>
 <result pre="S binding to DPP4. Figure 6. Reduced MERS-CoV S-driven host" exact="cell entry" post="is caused by inefficient S protein binding to DPP4"/>
 <result pre="polymorphic amino acid residues. In order to investigate whether reduced" exact="MERS-CoV" post="S-driven host cell entry and MERS-CoV replication is due"/>
 <result pre="residues. In order to investigate whether reduced MERS-CoV S-driven host" exact="cell entry" post="and MERS-CoV replication is due to inefficient MERS-CoV S"/>
 <result pre="to investigate whether reduced MERS-CoV S-driven host cell entry and" exact="MERS-CoV" post="replication is due to inefficient MERS-CoV S binding to"/>
 <result pre="host cell entry and MERS-CoV replication is due to inefficient" exact="MERS-CoV" post="S binding to DPP4 harboring amino acid polymorphisms at"/>
 <result pre="with a soluble S protein comprising the S1 subunit of" exact="MERS-CoV" post="S fused to the Fc region of human IgG."/>
 <result pre="cells were cotransfected with expression plasmids coding for soluble, Fc-tagged" exact="MERS-CoV" post="S1 (solMERS-S1-Fc) and the indicated DPP4 variant containing a"/>
 <result pre="expression levels for solMERS-S1-Fc and DPP4. (B) For quantification of" exact="MERS-CoV" post="S/DPP4 interaction we first normalized the DPP4 signals against"/>
 <result pre="normalized the DPP4 signals against the respective solMERS-S1-Fc signals. Then," exact="MERS-CoV" post="S/DPP4 interaction was set as 100% for wildtype (WT)"/>
 <result pre="Error bars indicate the SEM. Statistical significance of differences in" exact="MERS-CoV" post="S/DPP4 interaction between WT and mutant DPP4 was analyzed"/>
 <result pre="posttest ( p &amp;gt; 0.05, ns; p ≤ 0.05, *; p ≤ 0.001, ***). (C) Soluble" exact="MERS-CoV" post="S1-Fc was incubated with BHK-21 cells expressing wildtype (WT)"/>
 <result pre="p &amp;gt; 0.05, ns; p ≤ 0.05, *; p ≤ 0.01, **; p ≤ 0.001, ***). Discussion Host" exact="cell entry" post="of MERS-CoV critically depends on the interaction between the"/>
 <result pre="*; p ≤ 0.01, **; p ≤ 0.001, ***). Discussion Host cell entry of" exact="MERS-CoV" post="critically depends on the interaction between the viral S"/>
 <result pre="levels [ 48], and the risk of fatal outcome of" exact="MERS-CoV" post="infection has been made [ 49]. Moreover, alanine scanning"/>
 <result pre="49]. Moreover, alanine scanning mutagenesis identified DPP4 residues critical for" exact="MERS-CoV" post="entry, including K267, L294, I295, R317 and R336 ["/>
 <result pre="50, 51]. However, the impact of natural-occurring variations on host" exact="cell entry" post="of MERS-CoV has not been addressed so far. We"/>
 <result pre="the impact of natural-occurring variations on host cell entry of" exact="MERS-CoV" post="has not been addressed so far. We identified DPP4"/>
 <result pre="far. We identified DPP4 polymorphisms that reduce S protein-driven host" exact="cell entry" post="and replication of authentic MERS-CoV by lowering the binding"/>
 <result pre="reduce S protein-driven host cell entry and replication of authentic" exact="MERS-CoV" post="by lowering the binding efficiency of MERS-CoV S to"/>
 <result pre="replication of authentic MERS-CoV by lowering the binding efficiency of" exact="MERS-CoV" post="S to DPP4, suggesting that the DPP4 phenotype may"/>
 <result pre="suggesting that the DPP4 phenotype may impact the course of" exact="MERS-CoV" post="infection. Western blot analysis, flow cytometry and confocal laser"/>
 <result pre="(K267E, K267N, A291P and Δ346–348) severely reduced S protein-driven host" exact="cell entry." post="As DPP4 Δ346–348 was shown to be incompatible with"/>
 <result pre="with robust cell surface transport but able to interact with" exact="MERS-CoV" post="S in co-IP analysis, we conclude that the reduction"/>
 <result pre="to insufficient DPP4 surface levels. In contrast, reduction of host" exact="cell entry" post="by K267E, K267N and A291P could not be explained"/>
 <result pre="reduced DPP4 expression and these polymorphisms were thus further investigated." exact="MERS-CoV" post="infection of BHK-21 cells transfected to express DPP4 WT"/>
 <result pre="revealed that K267E or A291P were not compatible with robust" exact="MERS-CoV" post="replication. Finally, co-IP analyses and binding studies with soluble"/>
 <result pre="MERS-CoV replication. Finally, co-IP analyses and binding studies with soluble" exact="MERS-CoV" post="S showed that these DPP4 polymorphisms reduced S protein"/>
 <result pre="at the crystal structure of the complex consisting of the" exact="MERS-CoV" post="S receptor binding domain bound to DPP4, these observations"/>
 <result pre="a surprise. DPP4 residue K267 has been reported to contact" exact="MERS-CoV" post="S residues G538 and D539, including a salt bridge"/>
 <result pre="DPP4 residue A291, which has been reported to contact the" exact="MERS-CoV" post="S residue E513, no information on the type of"/>
 <result pre="to the small side chain of alanine) abolishes/decreases interaction with" exact="MERS-CoV" post="S residue E513 (Supplementary Figure 1). In contrast to"/>
 <result pre="alanine and thus might be efficiently contacted by E513 of" exact="MERS-CoV" post="S, which is why we did not observe any"/>
 <result pre="we did not observe any impact of polymorphisms A291V on" exact="MERS-CoV" post="S-driven entry and MERS-CoV S MERS-CoV S binding/interaction (Supplementary"/>
 <result pre="any impact of polymorphisms A291V on MERS-CoV S-driven entry and" exact="MERS-CoV" post="S MERS-CoV S binding/interaction (Supplementary Figure 1). The observation"/>
 <result pre="of polymorphisms A291V on MERS-CoV S-driven entry and MERS-CoV S" exact="MERS-CoV" post="S binding/interaction (Supplementary Figure 1). The observation that certain"/>
 <result pre="Figure 1). The observation that certain polymorphisms in DPP4 reduced" exact="MERS-CoV" post="S binding and viral entry triggered the question whether"/>
 <result pre="binding and viral entry triggered the question whether residues in" exact="MERS-CoV" post="S that are in direct contact with the respective"/>
 <result pre="such a concept. Thus, we found that residue 539 in" exact="MERS-CoV" post="S which contacts DPP4 residue 267 is polymorphic, with"/>
 <result pre="S which contacts DPP4 residue 267 is polymorphic, with certain" exact="MERS-CoV" post="variants harboring an asparagine instead of an aspartate residue"/>
 <result pre="(Supplementary Figure 2). Moreover, and more interestingly, D539N slightly rescued" exact="MERS-CoV" post="S-driven entry from the negative effect exerted by DPP4"/>
 <result pre="DPP4 polymorphism K267N (Supplementary Figure 2). Similarly, residue 510 in" exact="MERS-CoV" post="S, which is known to interact with DPP4 residues"/>
 <result pre="slightly increased entry via DPP4 harboring polymorphism Y322H and allowed" exact="MERS-CoV" post="S to use DPP4 with polymorphism R317K with the"/>
 <result pre="of these effects was statistically significant and that DPP4 and" exact="MERS-CoV" post="S polymorphisms occur with low frequency. Although it is"/>
 <result pre="polymorphisms have emerged as a result of evolutionary pressure from" exact="MERS-CoV" post="infections, our results suggest that certain existing DPP4 polymorphism(s)"/>
 <result pre="that certain existing DPP4 polymorphism(s) might foster the emergence of" exact="MERS-CoV" post="variants with altered biological properties. The polymorphisms studied here"/>
 <result pre="recent evidence suggests that sequence variations between African and Arabian" exact="MERS-CoV" post="might be a factor [ 53, 57]. More importantly,"/>
 <result pre=", Brown VR , et al. Replication and shedding of" exact="MERS-CoV" post="in upper respiratory tract of inoculated dromedary camels ."/>
 <result pre="SA , Farraj SA , et al. Evidence for camel-to-human" exact="transmission" post="of MERS coronavirus. N Engl J Med. 2014 Jun"/>
 <result pre=", Al Dhahiry SH , Reusken CB , et al." exact="Middle East respiratory syndrome" post="coronavirus in dromedary camels: an outbreak investigation. Lancet Infect"/>
 <result pre="DC , Alqasrawi S , et al. Hospital-associated outbreak of" exact="Middle East respiratory syndrome" post="coronavirus: a serologic, epidemiologic, and clinical description . Clin"/>
 <result pre="A , Perl TM , et al. Hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirus. N Engl J Med. 2013 Aug 1; 369("/>
 <result pre="DK , et al. Molecular epidemiology of hospital outbreak of" exact="Middle East respiratory syndrome," post="Riyadh, Saudi Arabia, 2014 . Emerg Infect Dis. 2015"/>
 <result pre="10.3201/eid2111.150944 26484549 10 collab: Korea Centers for Disease Control Prevention" exact="Middle East respiratory syndrome" post="coronavirus outbreak in the Republic of Korea, 2015. Osong"/>
 <result pre=", Tomczyk SM , Al-Asmari AM , et al. 2014" exact="MERS-CoV" post="outbreak in Jeddah–a link to health care facilities. N"/>
 <result pre="EJ , Ryu YW , et al. Epidemiological investigation of" exact="MERS-CoV" post="spread in a single hospital in South Korea, May"/>
 <result pre=", Schipper D , et al. Differential expression of the" exact="Middle East respiratory syndrome" post="coronavirus receptor in the upper respiratory tracts of humans"/>
 <result pre="Shi X , Jiang L , et al. Structure of" exact="MERS-CoV" post="spike receptor-binding domain complexed with human receptor DPP4 ."/>
 <result pre=", Holmes KV. Role of the spike glycoprotein of human" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in virus entry and syncytia formation ."/>
 <result pre="24098509 19 Shirato K , Kawase M , Matsuyama S." exact="Middle East respiratory syndrome" post="coronavirus infection mediated by the transmembrane serine protease TMPRSS2"/>
 <result pre="respiratory syndrome coronavirus infection mediated by the transmembrane serine protease" exact="TMPRSS2" post=". J Virol. 2013 Dec; 87( 23): 12552– 12561."/>
 <result pre="L , et al. Mutations in the spike protein of" exact="Middle East respiratory syndrome" post="coronavirus transmitted in Korea increase resistance to antibody-mediated Neutralization"/>
 <result pre="al. The Hemagglutinin of bat-associated Influenza Viruses is activated by" exact="TMPRSS2" post="for pH-dependent entry into bat but not human cells"/>
 <result pre=", Milne-Price S , et al. Host species restriction of" exact="Middle East respiratory syndrome" post="coronavirus through its receptor, dipeptidyl peptidase 4 . J"/>
 <result pre="al. Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study ."/>
 <result pre="al. Identification of residues on human receptor DPP4 critical for" exact="MERS-CoV" post="binding and entry . Virology. 2014 Dec; 471-473: 49–"/>
 <result pre="DK , Oladipo JO , Perera RA , et al." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015 ."/>
 <result pre=", Hui KPY , Perera R , et al. MERS" exact="coronaviruses" post="from camels in Africa exhibit region-dependent genetic diversity. Proc"/>
 <result pre="K , Melaku SK , Kawachi K , et al." exact="Middle East respiratory syndrome" post="coronavirus in Dromedaries in Ethiopia Is Antigenically different from"/>
</results>
